Finally, we discussed the possibility that ZEB1 could be used as a biomarker for HCC and founding that ZEB1 is able to serve as a potential biomarker of HCC and helps to understanding the prognosis of HCC patients. Here, ZEB1 is linked to hepatocellular carcinoma.